Michael J. Vinikoor,Edford Sinkala,Annie Kanunga,Mutinta Muchimba,Bright Nsokolo,Roma Chilengi,Gilles Wandeler,Joseph Mulenga,Tina Chisenga,Debika Bhattacharya,Michael S. Saag,Graham R. Foster,Michael Fried,Paul Kelly
出处
期刊:World Journal of Hepatology日期:2018-09-27卷期号:10 (9): 622-628被引量:6
AIMTo characterize antiviral therapy eligibility among hepatitis B virus (HBV)-infected adults at a university hospital in Zambia. CONCLUSIONApproximately one in ten HBV-monoinfected Zambians were eligible for antivirals.Many had indeterminate phenotype and needed clinical follow-up.623 WJH|www.wjgnet.com